| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 19, 2013 | Pechala's Reports | Lubomir Pechala | ALLERGAN INC (AGN) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | May 19, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 18, 2013 | Stock Traders Daily | Thomas H Kee Jr. | Trading Report for (AGN). A detailed report, including free correlated market analysis, and updates. | 5 | $57.50 | | May 17, 2013 | Pechala's Reports | Frantisek Pechala | ALLERGAN INC (AGN) 12-months forecast | 1 | $15 | | May 17, 2013 | Reuters Investment Profile | N/A | Allergan Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | | May 16, 2013 | New Constructs, LLC | N/A | AGN: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 16, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - ALLERGAN, INC. (AGN-N) | 12 | $25 | | May 16, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Large CAP Pharma | 17 | $195.50 | | May 16, 2013 | Jefferson Research | N/A | Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALLERGAN INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 11 | $20 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: ALLERGAN -- AGN | 1 | $11.50 |
|
View All Reports for AGN ... |
|
|
0.99(0.99%) May 17, 4:00PM EDT|After Hours
:
100.74